Researchers found differences in gut bacteria between children with autism and typically developing children but caution that more research is needed to clarify these associations and their therapeutic potential.
J&J unveils Varipulse data at AF Symposium
Dive Brief: More than 75% of clinical trial participants were free from atrial arrhythmia recurrence one year after being treated with Johnson & Johnson’s Varipulse